Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Lindner Center of HOPE
• Collaborators: Shire; University of Cincinnati
• Treatments: Lisdexamfetamine Dimesylate

Criteria

Inclusion Criteria:

• Patients will meet DSM-IV criteria for BED for at least the last 6 months

Exclusion Criteria:

• Women who are pregnant or lactating and women of childbearing potential who are not taking adequate contraceptive measures. If there is a possibility a female subject might be pregnant, a pregnancy test will be performed. (All women of childbearing potential will have a negative pregnancy test before entering the study.)

• Subjects who are displaying clinically significant suicidality or homicidality.

• A current or recent (within 6 months of the start of study medication) DSM-IV diagnosis of substance abuse or dependence